Literature DB >> 21830960

New options in anticoagulation for atrial fibrillation.

Gregory J del Zoppo, Misha Eliasziw.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21830960     DOI： 10.1056/NEJMe1107516

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  9 in total

1.  Optimizing the dose of dabigatran etexilate.

Authors:  John Posner
Journal:  Br J Clin Pharmacol       Date:  2012-11       Impact factor: 4.335

2.  Practical Guide to Direct New Oral Anticoagulant Use for Secondary Stroke Prevention in Atrial Fibrillation.

Authors:  Rochelle Sweis; José Biller
Journal:  Curr Treat Options Cardiovasc Med       Date:  2016-04

3.  Atrial fibrillation and stroke prevention: is warfarin still an option? Yes: Debate at the Controversies in Neurology Congress, Beijing, October 2011.

Authors:  J David Spence
Journal:  J Neural Transm (Vienna)       Date:  2012-12-12       Impact factor: 3.575

4.  Dabigatran and rivaroxaban use in atrial fibrillation patients on hemodialysis.

Authors:  Kevin E Chan; Elazer R Edelman; Julia B Wenger; Ravi I Thadhani; Franklin W Maddux
Journal:  Circulation       Date:  2015-01-16       Impact factor: 29.690

Review 5.  Plasminogen activators and ischemic stroke: conditions for acute delivery.

Authors:  Gregory J del Zoppo
Journal:  Semin Thromb Hemost       Date:  2013-03-28       Impact factor: 4.180

Review 6.  Rivaroxaban: a review of its use in the prevention of stroke and systemic embolism in patients with atrial fibrillation.

Authors:  Natalie J Carter; Greg L Plosker
Journal:  Drugs       Date:  2013-05       Impact factor: 9.546

7.  Addressing barriers to optimal oral anticoagulation use and persistence among patients with atrial fibrillation: Proceedings, Washington, DC, December 3-4, 2012.

Authors:  Paul L Hess; Michael J Mirro; Hans-Christoph Diener; John W Eikelboom; Sana M Al-Khatib; Elaine M Hylek; Hayden B Bosworth; Bernard J Gersh; Daniel E Singer; Greg Flaker; Jessica L Mega; Eric D Peterson; John S Rumsfeld; Benjamin A Steinberg; Ajay K Kakkar; Robert M Califf; Christopher B Granger
Journal:  Am Heart J       Date:  2014-04-24       Impact factor: 4.749

8.  A pilot randomized controlled trial of a decision support tool to improve the quality of communication and decision-making in individuals with atrial fibrillation.

Authors:  Liana Fraenkel; Richard L Street; Virginia Towle; John R O'Leary; Lynne Iannone; Peter H Van Ness; Terri R Fried
Journal:  J Am Geriatr Soc       Date:  2012-08-02       Impact factor: 5.562

Review 9.  Intracerebral haemorrhage associated with antithrombotic treatment: translational insights from experimental studies.

Authors:  Arne Lauer; Waltraud Pfeilschifter; Chris B Schaffer; Eng H Lo; Christian Foerch
Journal:  Lancet Neurol       Date:  2013-03-18       Impact factor: 44.182
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.